MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday that Canadian-produced GMP Beacon Medical cannabis oil and inhalation cartridges have launched in the Australian medical marijuana market.
The cannabis oil portfolio features a high CBD Isolate (THC-free) oil, a balanced oil and a THC dominant full spectrum oil made with Beacon's popular medical flower strains.
The inhalation cartridges include flavor-forward options popular with patients in the Canadian market and strain-specific full-spectrum cartridges that utilize flower varieties already favored by Beacon Medical patients.
With Beacon Medical's Pink Kush and GSC products available in flower, oil and inhalation formats, the company provides physicians and patients with three delivery methods ...